The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology

The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology
Antiplatelet therapy administered in critically ill adult patients suffering from COVID-19 does not have an improvement in the number of organ-support ...
A recent meta-analysis revealed that there was no effect on the short term mortality of the patients hospitalized with COVId-19 with intensified antic ...
Antithrombotic therapy in clinically stable, non-hospitalized COVID-19 patients does not offer protection against adverse cardiovascular or pulmonary ...